( May 8, 2025, 11:41 AM EDT) -- FORT WORTH, Texas — Companies representing the interests of drug compounders on May 7 filed a notice of interlocutory appeal to the Fifth Circuit U.S. Court of Appeals immediately after a Texas federal judge in an order under seal granted two motions for summary judgment in a dispute over whether the agency properly determined that the shortage of tirzepatide, a drug for diabetes and weight loss, had ended when it removed the drug from the agency’s drug shortage list....